Clough Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-26,041
| Closed | -$9.16M | – | 241 |
|
|
2023
Q2 | $9.16M | Sell |
26,041
-10,480
| -29% | -$3.53M | 0.92% | 38 |
|
|
2023
Q1 | $11.5M | Sell |
36,521
-10,690
| -23% | -$3.21M | 1.24% | 26 |
|
|
2022
Q4 | $13.6M | Buy |
47,211
+32,530
| +222% | +$9.91M | 1.38% | 20 |
|
|
2022
Q3 | $4.25M | Sell |
14,681
-1,570
| -10% | -$452K | 0.63% | 37 |
|
|
2022
Q2 | $4.58M | Sell |
16,251
-41,899
| -72% | -$11.2M | 0.59% | 40 |
|
|
2022
Q1 | $15.2M | Sell |
58,150
-48,960
| -46% | -$11.6M | 1.16% | 37 |
|
|
2021
Q4 | $23.5M | Buy |
107,110
+17,500
| +20% | +$3.4M | 1.58% | 14 |
|
|
2021
Q3 | $16.3M | Hold |
89,610
| – | – | 1.01% | 41 |
|
|
2021
Q2 | $18.1M | Buy |
89,610
+8,330
| +10% | +$1.74M | 1.01% | 47 |
|
|
2021
Q1 | $17.5M | Sell |
81,280
-5,320
| -6% | -$1.17M | 1.13% | 51 |
|
|
2020
Q4 | $20.5M | Buy |
86,600
+11,290
| +15% | +$2.59M | 1.49% | 25 |
|
|
2020
Q3 | $20.5M | Buy |
75,310
+44,710
| +146% | +$12.3M | 1.66% | 23 |
|
|
2020
Q2 | $8.88M | Sell |
30,600
-11,250
| -27% | -$3.05M | 0.88% | 40 |
|
|
2020
Q1 | $9.96M | Buy |
41,850
+5,110
| +14% | +$1.17M | 1.21% | 31 |
|
|
2019
Q4 | $8.04M | Buy |
36,740
+5,996
| +20% | +$1.21M | 0.69% | 51 |
|
|
2019
Q3 | $5.21M | Sell |
30,744
-300
| -1% | -$53.1K | 0.55% | 51 |
|
|
2019
Q2 | $5.69M | Sell |
31,044
-27,405
| -47% | -$4.79M | 0.56% | 65 |
|
|
2019
Q1 | $10.8M | Buy |
58,449
+13,660
| +30% | +$2.52M | 0.94% | 34 |
|
|
2018
Q4 | $7.42M | Sell |
44,789
-923
| -2% | -$160K | 0.87% | 44 |
|
|
2018
Q3 | $8.81M | Sell |
45,712
-5,500
| -11% | -$979K | 0.83% | 44 |
|
|
2018
Q2 | $8.7M | Sell |
51,212
-7,830
| -13% | -$1.21M | 0.78% | 41 |
|
|
2018
Q1 | $9.62M | Sell |
59,042
-6,640
| -10% | -$1.08M | 0.92% | 42 |
|
|
2017
Q4 | $9.84M | Buy |
65,682
+2,800
| +4% | +$415K | 0.82% | 44 |
|
|
2017
Q3 | $9.56M | Sell |
62,882
-1,500
| -2% | -$226K | 0.64% | 51 |
|
|
2017
Q2 | $8.3M | Sell |
64,382
-110,766
| -63% | -$13.3M | 0.58% | 49 |
|
|
2017
Q1 | $15.3M | Buy |
175,148
+65,800
| +60% | +$5.79M | 0.97% | 32 |
|
|
2016
Q4 | $8.06M | Buy |
109,348
+44,448
| +68% | +$3.62M | 0.53% | 59 |
|
|
2016
Q3 | $5.66M | Sell |
64,900
-18,900
| -23% | -$1.79M | 0.3% | 94 |
|
|
2016
Q2 | $7.21M | Sell |
83,800
-18,075
| -18% | -$1.56M | 0.39% | 85 |
|
|
2016
Q1 | $8.1M | Sell |
101,875
-67,850
| -40% | -$6.14M | 0.38% | 79 |
|
|
2015
Q4 | $21.4M | Sell |
169,725
-27,225
| -14% | -$3.29M | 1% | 32 |
|
|
2015
Q3 | $20.5M | Buy |
+196,950
| New | +$25.3M | 0.89% | 39 |
|
Other funds holding VRTX
